NCT05746481 2026-01-22
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
University of Pittsburgh
Phase 2 Terminated
University of Pittsburgh
University of Kentucky
Blueprint Medicines Corporation
Hoosier Cancer Research Network
Tufts Medical Center
Cedars-Sinai Medical Center